Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial
Jose I Bernardino, Amanda Mocroft, Patrick W Mallon, Cedrick Wallet, Jan Gerstoft, Charlotte Russell, Peter Reiss, Christine Katlama, Stephane De Wit, Laura Richert, Abdel G. Babiker, Antonio Buño, Antonella Castagna, Pierre-Marie Girard, Genevieve Chene, Francois Raffi, Jose R Arribas, NEAT001/ANRS143 Study Group
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial'. Together they form a unique fingerprint.